DEVELOPMENT AND TESTING OF A LOW-COST INACTIVATION BUFFER THAT ALLOWS DIRECT SARS-COV-2 DETECTION IN SALIVA
Brandon Bustos-Garcia, Sylvia Garza-Manero, Nallely Cano-Dominguez, Dulce Maria Lopez Sanchez, Gonzalo Salgado Montes de Oca, Alfonso Salgado-Aguayo, Felix Recillas-Targa, Santiago Avila-Rios, View ORCID ProfileVictor Julian Valdes
doi: https://doi.org/10.1101/2021.11.26.21266918
Brandon Bustos-Garcia
1Department of Cell Biology and Development, Institute of Cellular Physiology (IFC), National Autonomous University of Mexico (UNAM), Mexico City, Mexico
Sylvia Garza-Manero
2Department of Molecular Genetics, Institute of Cellular Physiology (IFC), National Autonomous University of Mexico (UNAM), Mexico City, Mexico
Nallely Cano-Dominguez
1Department of Cell Biology and Development, Institute of Cellular Physiology (IFC), National Autonomous University of Mexico (UNAM), Mexico City, Mexico
Dulce Maria Lopez Sanchez
3Centre for Research in Infectious Diseases of the National Institute of Respiratory Diseases (CIENI/INER), Mexico City, Mexico
Gonzalo Salgado Montes de Oca
3Centre for Research in Infectious Diseases of the National Institute of Respiratory Diseases (CIENI/INER), Mexico City, Mexico
Alfonso Salgado-Aguayo
4Laboratory of Research in Rheumatic Diseases. National Institute of Respiratory Diseases (INER), Mexico City, Mexico
Felix Recillas-Targa
2Department of Molecular Genetics, Institute of Cellular Physiology (IFC), National Autonomous University of Mexico (UNAM), Mexico City, Mexico
Santiago Avila-Rios
3Centre for Research in Infectious Diseases of the National Institute of Respiratory Diseases (CIENI/INER), Mexico City, Mexico
Victor Julian Valdes
1Department of Cell Biology and Development, Institute of Cellular Physiology (IFC), National Autonomous University of Mexico (UNAM), Mexico City, Mexico
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted November 28, 2021.
DEVELOPMENT AND TESTING OF A LOW-COST INACTIVATION BUFFER THAT ALLOWS DIRECT SARS-COV-2 DETECTION IN SALIVA
Brandon Bustos-Garcia, Sylvia Garza-Manero, Nallely Cano-Dominguez, Dulce Maria Lopez Sanchez, Gonzalo Salgado Montes de Oca, Alfonso Salgado-Aguayo, Felix Recillas-Targa, Santiago Avila-Rios, Victor Julian Valdes
medRxiv 2021.11.26.21266918; doi: https://doi.org/10.1101/2021.11.26.21266918
DEVELOPMENT AND TESTING OF A LOW-COST INACTIVATION BUFFER THAT ALLOWS DIRECT SARS-COV-2 DETECTION IN SALIVA
Brandon Bustos-Garcia, Sylvia Garza-Manero, Nallely Cano-Dominguez, Dulce Maria Lopez Sanchez, Gonzalo Salgado Montes de Oca, Alfonso Salgado-Aguayo, Felix Recillas-Targa, Santiago Avila-Rios, Victor Julian Valdes
medRxiv 2021.11.26.21266918; doi: https://doi.org/10.1101/2021.11.26.21266918
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11625)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3391)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (410)
- Public and Global Health (6022)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)